Is the association of hypertension and panic disorder explained by clustering of autonomic panic symptoms in hypertensive patients?

Journal of Affective Disorders

Volumn 111, Issue 2-3, 2008, Pages 344-350

  Davies, Simon J C ^a   Jackson, Peter R ^b   Lewis, Glyn ^a   Hood, Sean D ^c   Nutt, David J ^a   Potokar, John P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Autonomic nervous system; Factor analysis; Hypertension; Panic attack; Panic disorder; Serotonin

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

AGED; ARTICLE; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FLUSHING; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PANIC; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; SWEATING; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CLUSTER ANALYSIS; COMORBIDITY; FACTOR ANALYSIS, STATISTICAL; FEMALE; FLUSHING; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; PANIC DISORDER; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEROTONIN; SEVERITY OF ILLNESS INDEX; SWEATING; TACHYCARDIA;

EID: 54049128510     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.03.003     Document Type: Article

References (37)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, third edition revised (1987), American Psychiatric Association, Washington D.C
2. Bago M., and Dean C. Sympathoinhibition from ventrolateral periaqueductal gray mediated by 5-HT(1A) receptors in the RVLM. Am. J. Physiol., Regul. Integr. Comp. Physiol. 280 (2001) R976-R984
3. Bell C.C., Hildreth C.J., Jenkins E.J., and Carter C. The relationship of isolated sleep paralysis and panic disorder to hypertension. J. Natl. Med. Assoc. 80 (1988) 289-294
4. Briggs A.C., Stretch D.D., and Brandon S. Subtyping of panic disorder by symptom profile. BMJ 163 (1993) 201-209
5. Coplan J.D., Pine D.S., Papp L.A., and Gorman J.M. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine. Psychopharmacol. Bull. 33 (1997) 193-204
6. Coupland N.J., Wilson S.J., Potokar J.P., Bell C., and Nutt D.J. A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes. Int. Clin. Psychopharmacol. 10 (1995) 229-238
7. Cox B.J., Swinson R.P., Endler N.S., and Norton G.R. The symptom structure of panic attacks. Compr. Psychiatry 35 (1994) 349-353
8. Davies S.J.C., Ghahramani P., Jackson P.R., Noble T.W., Hardy P.G., Hippisley-Cox J., Yeo W.W., and Ramsay L.E. Association of Panic Disorder and Panic Attacks with Hypertension. Am. J. Med. 107 (1999) 310-316
9. Davies S.J.C., Jackson P.R., Ramsay L.E., Ghahramani P., Palmer R.L., and Hippisley-Cox J. No evidence that panic attacks are associated with the white coat effect in hypertension. J. Clin. Hypertens. 5 (2003) 145-152
10. Davies S.J.C., Hood S.D., Argyropoulos S.V., Morris K., Bell C., Witchel H.J., Jackson P.R., Nutt D.J., and Potokar J.P. Depleting Serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders. J. Clin. Psychopharmacol. 26 (2006) 414-418
11. Davies S.J.C., Lowry C.A., and Nutt D.J. Panic and Hypertension - brothers in arms through 5-HT?. J. Psychopharmacol. 21 (2007) 560-563
12. de Beurs E., Garssen B., Buikhuisen M., Lange A., van Balkom A., and van Dyck R. Continuous monitoring of panic. Acta Psychiatr. Scand. 90 (1994) 38-45
13. Ehlers A., Mayou R.A., Sprigings D.C., and Birkhead J. Psychological and perceptual factors associated with arrhythmias and benign palpitations. Psychosom. Med. 62 (2000) 693-702
14. Esler M.D., Jennings G.L., and Lambert G.W. Release of noradrenaline into the cerebrovascular circulation in patients with primary hypertension. J. Hypertens. Suppl. 6 (1988) S494-S496
15. Esler M., Jennings G., Korner P., Willett I., Dudley F., Hasking G., Anderson W., and Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11 (1988) 3-20
16. Grassi G., and Kiowski W. Is the autonomic dysfunction the missing link between panic disorder, hypertension and cardiovascular disease?. J. Hypertens. 20 (2002) 2347-2349
17. Katon W. Panic disorder and somatization. Am. J. Med. 77 (1984) 101-106
18. Katon W. Panic disorder: epidemiology, diagnosis, and treatment in primary care. J. Clin. Psychiatry. 47 10(suppl) (1986) 21-27
19. Kristensen A.S., and Mors O. The symptom structure of panic disorder, agoraphobia and social phobia. Factor analysis of the ICD-10 anxiety symptoms investigated using two different approaches, 25th Stress and Anxiety Research Society Conference Amsterdam vol. 248 (2004) (Abstract)
20. Lambert E.A., Thompson J., Schlaich M., Laude D., Elghozi J.L., Esler M.D., and Lambert G.W. Sympathetic and cardiac baroreflex function in panic disorder. J. Hypertens. 20 (2002) 2445-2451
21. MacDonald L.A., Sackett D.L., Haynes R.B., and Taylor D.W. Labelling in hypertension: a review of the behavioural and psychological consequences. J. Chron. Dis. 37 (1984) 933-942
22. Mathias C.J. To stand on one's own legs. Clin. Med. 2 (2002) 237-245
23. Noyes R., Clancy J., Hoenk P.R., and Slymen D.J. Anxiety neurosis and physical illness. Compr. Psychiatry. 19 (1978) 407-413
24. Nutt D.J. Altered central alpha 2-adrenoceptor sensitivity in panic disorder. Arch. Gen. Psychiatry. 46 (1989) 165-169
25. Pio-Abreu J.L., Ramalheira C., and Valente J.M. Towards a 'map' of panic: structure of the bodily symptoms. Acta. Psychiatr. Scand. 97 (1998) 66-70
26. Polyák J. How should we manage cardiovascular panic disorder accompanied by hypertension?. J. Hypertens. 19 (2001) S64 (Abstract)
27. Segui J., Salvador-Carulla L., Garcia L., Canet J., Ortiz M., and Farre J.M. Semiology and subtyping of panic disorders. Acta. Psychiatr. Scand. 97 (1998) 272-277
28. Sever P., Beevers G., Bulpitt C., Lever A., Ramsay L., Reid J., and Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 306 (1993) 983-987
29. Shioiri T., Someya T., Murashita J., and Takahashi S. The symptom structure of panic disorder: a trial using factor and cluster analysis. Acta. Psychiatr. Scand. 93 (1996) 80-86
30. Walther M.M., Keiser H.R., and Linehan W.M. Pheochromocytoma: evaluation, diagnosis, and treatment. World J. Urol. 17 (1999) 35-39
31. Weissman M.M., Markowitz J.S., Ouellette R., Greenwald S., and Kahn J.P. Panic Disorder and Cardiovascular/ Cerebrovascular Problems: Results from a Community Survey. Am. J. Psychiatry. 147 (1990) 1504-1508
32. Wilkinson D.J., Thompson J.M., Lambert G.W., Jennings G.L., Schwarz R.G., Jeffreys D., Turner A.G., and Esler M.D. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch. Gen. Psychiatry. 55 (1998) 511-520
33. Williams J.B.W., Gibbon M., First M.B., Spitzer R.L., Davies M., Borus J., Howes M.J., Kane J., Pope Jr. H.G., Rounsaville B., and Wittchen H. The structured clinical interview for the DSM-III-R (SCID) II: Multisite Test-Retest Reliability. Arch. Gen. Psychiatry. 49 (1992) 630-636
34. Wing L.M., Reid J.L., Davies D.S., Neill E.A., Tippett P., and Dollery C.T. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension. Eur. J. Clin. Pharmacol. 12 (1977) 463-469
35. Yeragani V.K., Pohl R., Berger R., Balon R., Ramesh C., Glitz D., Srinivasan K., and Weinberg P. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res. 46 (1993) 89-103
36. Yeragani V.K., Sobolewski E., Igel G., Johnson C., Jampala V.C., Kay J., Hillman N., Yeragani S., and Vempati S. Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records. Psychiatry Res. 78 (1998) 89-99
37. Yeragani V.K., Pohl R., Jampala V.C., Balon R., Ramesh C., and Srinivasan K. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress. Anxiety 11 (2000) 126-130